Skip to main content
Premium Trial:

Request an Annual Quote

Shoreline Biome Inks Distribution Deal With Inqaba Biotec for Sub-Saharan Africa

NEW YORK — Shoreline Biome said on Thursday that it has signed an agreement to distribute its microbiome research products and services in sub-Saharan Africa through Inqaba Biotechnical Industries.

Financial and other terms of the deal were not disclosed.

Shoreline, founded in 2015, offers all-in-one microbiome assay kits, as well as related analysis software, designed to work on long-read Pacific Biosciences and Oxford Nanopore sequencing platforms and Illumina's short-read sequencing platform.

Inqaba Biotec, based in South Africa with offices in Ghana, Kenya, Nigeria, Tanzania, and Senegal, distributes a range of life science and molecular diagnostics products. It will also use Shoreline's products to offer strain identification services to microbiome researchers on its PacBio system.

In early 2018, Farmington, Connecticut-based Shoreline raised $1.1 million in private funding.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.